Premium cataract lens marketing: Medicare rules, upgrade disclosures and glasses-free claims

Cataract surgery is a procedure where a Medicare patient may be asked, before surgery, whether they want to pay extra for an upgrade. The upgrade is a lens that also corrects presbyopia or astigmatism, sold under names like premium, lifestyle or advanced technology lens. The pitch is easy to write and easy to get wrong: it touches Medicare billing rules, a notice the practice has to give before surgery, and claims about life without glasses that the FTC treats as health claims. This guide is for ophthalmology practices, cataract surgeons, ambulatory surgery centers and the agencies that write their pages, ads, seminars and counseling scripts.

Two related topics have their own guides and are not repeated here. Refractive surgery marketing, including what FDA tells patients about LASIK, enhancement wording and refractive financing, is in our LASIK marketing guide. Marketing for optometry practices, including the FTC Eyeglass and Contact Lens Rules, optical sales and recalls, is in our optometry marketing ideas guide. For macular degeneration and sudden vision loss wording, see retina practice marketing.

What Medicare covers and what it does not

Start every premium lens page from the coverage rule, because the rest of the copy depends on it. The Medicare.gov cataract surgery page says Part B may cover cataract surgery that implants conventional intraocular lenses, and that Part B covers one pair of eyeglasses with standard frames, or one set of contact lenses, after each cataract surgery that implants an intraocular lens. The patient’s deductible and coinsurance still apply to the covered surgery.

Two CMS rulings explain where the upgrade fits:

• CMS Ruling 05-01, dated and effective May 3, 2005, covers presbyopia-correcting lenses. It says a single presbyopia-correcting lens essentially provides what is otherwise achieved by two separate items, a conventional lens and eyeglasses or contact lenses, and that although such a lens may serve the same function as eyeglasses, it is neither eyeglasses nor contact lenses. So its presbyopia-correcting functionality does not fall into a Medicare benefit category and is not covered.
• CMS Ruling CMS-1536-R, dated and effective January 22, 2007, applies the same reasoning to astigmatism-correcting lenses: the astigmatism-correcting functionality is not covered.
• Under both rulings, the conventional part of the service stays covered. The beneficiary may request the upgraded lens in place of a conventional one, and is responsible for the facility and physician charges that exceed the charges for a conventional lens, including the extra work for insertion, fitting and vision acuity testing. Eye examinations to determine the refractive state of the eyes after a premium lens are non-covered.

CMS publishes a list of the lenses it recognizes as presbyopia-correcting, astigmatism-correcting or both; the copy we checked was last updated March 2026. If a page says an upgrade can be billed to the patient under these rulings, the lens you use should be on the current list. Check the list again before each campaign rather than relying on an older printout.

For marketing, this means the honest message is “Medicare covers your cataract surgery with a standard lens; an upgraded lens costs extra”, not “Medicare covers premium lenses” or “Medicare helps pay for your upgrade”. Medicare Advantage plans and supplemental coverage can differ, so do not state what a given patient will owe on a public page.

Notice before surgery, and the patient’s right to say no

The Medicare Claims Processing Manual, Chapter 32, turns the rulings into instructions. Three points from sections 120.3 and 120.4 shape every counseling script and landing page:

• Before the procedure, the facility and the physician must inform the beneficiary that Medicare will not pay for services specific to the insertion, adjustment or other subsequent treatments related to the presbyopia-correcting or astigmatism-correcting functionality of the lens.
• Because that functionality is outside a Medicare benefit category, an Advance Beneficiary Notice is not required. Although not required, CMS strongly encourages facilities and physicians to issue a Notice of Exclusion from Medicare Benefits to clearly identify the non-payable aspects of the upgrade.
• The physician and the facility may not charge for cataract extraction with a premium lens unless the beneficiary requests it, and may not require the beneficiary to request a premium lens as a condition of performing cataract surgery.

The manual says the patient must be informed; it encourages, rather than requires, a written notice. A written notice that the patient signs before surgery is still the clearest record that the patient was told, and it is the practice we would build the funnel around. Give it in plain language, with the itemized upgrade charges for that patient, and keep it with the chart.

The third point matters for marketing more than it seems. Copy that presents the upgrade as the normal path (“choose your lens package”, with no standard option shown), a counselor script that treats the standard lens as a fallback, or a deposit taken before the surgeon has seen the patient can all suggest the patient has no real choice. Show the covered standard lens option on the same page, with the same prominence, and let the patient ask for the upgrade.

Glasses-free, freedom from readers and other outcome claims

The headline claims for premium lenses are about outcomes: “glasses-free”, “never need readers again”, “see near, far and everything in between”. Under 15 U.S.C. 45 and 15 U.S.C. 52, deceptive acts and false advertisements for services and devices are unlawful, and the FTC’s Health Products Compliance Guidance (HPCG) explains how the FTC applies those laws to health claims.

Three points from the HPCG apply directly:

• Claims about health benefits or safety need competent and reliable scientific evidence, and the HPCG says that, as a general matter, this will need to be randomized, controlled human clinical testing.
• When an ad can reasonably be read more than one way, the advertiser has to substantiate each reading. “Glasses-free” can be read as “no glasses for anything, ever”.
• Anecdotes about individual experiences, including patient surveys, are not enough to substantiate a health claim.

The federal sources themselves are careful here. CMS Ruling 05-01 describes a presbyopia-correcting lens as intended to provide near, intermediate and distance vision, and qualifies freedom from eyeglasses or contact lenses as applying to a share of patients, not to all. CMS-1536-R says that for some patients an astigmatism-correcting lens may improve vision so much that nothing else is needed at certain distances. The National Eye Institute cataract surgery page says that once the eye is completely healed, a patient might need a new prescription for glasses or contact lenses to see clearly. None of these is a promise that a given patient will be free of glasses, and your copy should not make one.

Safer patterns:

• “Lens options that may reduce your need for glasses at some distances. Your surgeon will explain what each option can and cannot do for your eyes.”
• “Some patients still use glasses for some tasks after a premium lens.” Put it near any line about reduced dependence on glasses, not in a footnote.
• Describe what each lens type is designed to do in the words of its labeling, and let the surgeon’s evaluation decide candidacy.
• Do not use “glasses-free”, “perfect vision”, “20/20 or your money back” or “never need readers” as headlines.

Side effects belong in the same place as the benefits. The NEI page lists the risks of cataract surgery, including swelling, bleeding or infection, vision loss or double vision, changes in eye pressure, retinal detachment and secondary cataracts. Each lens also has its own labeling, including warnings; describe visual side effects from that labeling. The HPCG says ads that make an express or implied safety representation should include information about significant safety risks. Have your surgeons write or approve that paragraph; do not let a template or a vendor fill it in.

Lens and FDA wording

Intraocular lenses are class III devices. Under 21 CFR 886.3600, premarket approval has been required before an intraocular lens may be commercially distributed since May 28, 1976. Approval covers a specific lens for the indications in its labeling. It is not an approval of your practice, your surgeons or a patient’s result, so FDA should not appear next to outcome claims, and “the latest FDA technology” says nothing a patient can check. How a device is cleared or approved, and why its intended use limits what an ad can say, is in our device claims guide.

Leave lens brands and model names out of ads and landing page headlines. Brand names invite claims borrowed from a manufacturer’s materials that may not match your patients, and they are trademarks whose use counsel should clear. Describe the category instead: a lens that corrects astigmatism, a lens designed to provide a range of vision, a standard monofocal lens.

Prices, packages and financing

Upgrade pricing is easy to misread when covered and extra charges sit side by side. Keep the price pieces apart and visible:

• Say that the upgrade charge is in addition to what Medicare and the patient’s coverage pay for standard cataract surgery, and whether it is per eye.
• List what the upgrade charge includes, such as the lens upgrade, the extra testing and fitting, and the follow-up visits for the upgrade, and what it leaves out.
• Do not call the upgrade covered or “insurance-friendly” in ads. The rulings say the upgrade functionality is not covered.
• Starting-at prices, packages and free offers are covered in our guide to advertising cash prices, and monthly payment lines in our patient financing advertising guide.

Some cataract patients also have glaucoma or high eye pressure. Glaucoma pages carry their own claims and emergency wording; our guide to glaucoma practice marketing covers them.

Seminars, comanagement and referral sources

Premium lens programs can depend on referring optometrists, community seminars and outreach to senior living centers. Two rules apply. For patients covered by federal health care programs, 42 U.S.C. 1320a-7b(b) makes it a crime to knowingly and willfully offer or pay any remuneration to induce a referral for items or services paid for by those programs. Paying a referring office, a seminar host or a lead vendor per upgrade sold, or sharing the upgrade fee with whoever recommended it, needs counsel’s review before it starts. State laws can reach privately insured and self-pay patients as well, and set state by state who may share in fees.

Seminar and outreach copy should follow the same rules as the website. A free cataract seminar is an offer: say what attendees receive, and do not run screenings that end in an upgrade pitch on the same day without the surgeon’s evaluation.

Patient stories

Testimonials such as “I threw away my glasses” are strong in this category. Under 16 CFR 255.2(a), the advertiser must substantiate claims made through consumer endorsements as if it had made them directly, and consumer endorsements themselves are not competent and reliable scientific evidence. Under 255.2(b), an endorsement about a key attribute will likely be read as representing what consumers will generally achieve, so without substantiation for that, the ad should clearly and conspicuously disclose the generally expected performance.

Using a patient’s protected health information in marketing needs a written authorization under 45 CFR 164.508(a)(3). Get it before filming, keep it with the asset, and stop using the story if the patient revokes it.

Illustration: two ways to advertise lens upgrades

Illustration: [Practice name] runs an ad that reads “Cataract surgery with a premium lens: be glasses-free for life. Medicare covers your upgrade. The latest FDA technology. Choose your package today.” The landing page shows three lens packages and no standard option, takes a deposit online, and features a patient video saying “I will never need glasses again.” A referring office receives a fee for each upgrade. Each line raises a problem covered above: an outcome promise the federal sources do not support, a coverage claim the rulings contradict, an FDA reference used as an endorsement, a choice that does not look optional, a testimonial without a generally expected results disclosure, and a referral payment no one has reviewed.

Illustration: [Practice name] runs a page that reads “Medicare covers cataract surgery with a standard lens. If you want to reduce your need for glasses at some distances, you can ask about an upgraded lens, which costs extra and is not covered by Medicare. [Surgeon name] will check whether an upgrade suits your eyes, and will explain what it can and cannot do, including side effects. Some patients still use glasses for some tasks.” The standard and upgrade options appear side by side, the upgrade price is per eye with its inclusions listed, patients sign a notice before surgery naming the non-covered charges, and patient videos carry a written authorization and a results disclosure.

Checklist before a premium lens campaign goes live

• The page states that Medicare covers surgery with a standard lens, and that the upgrade costs extra and is not covered.
• The standard lens option is shown with the same prominence, and no copy or script makes the upgrade a condition of surgery.
• Patients are told before surgery what Medicare will not pay for, and the practice uses a signed written notice to record it.
• The lens is on the current CMS list, checked before the campaign.
• No “glasses-free”, “perfect vision” or promise headlines; reduced dependence on glasses is described as possible, not promised.
• Risks and visual side effects, approved by the surgeons, appear near the benefit claims.
• No lens brands in ads, and no FDA reference next to outcome claims.
• Upgrade prices are per eye, with inclusions listed; referral, seminar and vendor payments have been reviewed by counsel.
• Patient stories have written authorization and a generally expected results disclosure where needed.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For a cataract practice or surgery center, that means lens option pages that show the covered and upgrade paths side by side, ad copy that stays inside what the evidence supports, and consultation request forms that keep health information away from tracking tools. We do not decide which lens suits a patient, what Medicare or another payer covers for a given patient, or whether a referral arrangement is lawful; your surgeons, billing team and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• CMS Ruling 05-01: Presbyopia-correcting intraocular lenses (May 3, 2005)
• CMS Ruling CMS-1536-R: Astigmatism-correcting intraocular lenses (January 22, 2007)
• Medicare Claims Processing Manual, Chapter 32 (sections 120 to 120.4)
• CMS: Recognized presbyopia-correcting and astigmatism-correcting IOLs (last updated March 2026)
• Medicare.gov: Cataract surgery
• National Eye Institute: Cataract Surgery
• 21 CFR 886.3600: Intraocular lens
• 15 U.S.C. 45: Unfair methods of competition and unfair or deceptive acts or practices
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.508: Uses and disclosures for which an authorization is required

More in Dental, vision, hearing and therapy marketing